The global biological production industry is under pressure amidst challenging price restrictions, US health care reforms and reduced revenues. The agenda features a pharma QBD case study stream as well as keynote sessions, interactive workshops and networking activities.
Some of the key topics to be discussed are:
• Minimising Human Error To Optimise Manufacturing
• Successfully Meeting Virus Safety Requirements
• Designing A New Product Facility
• Successfully Designing A Single Use Facility
• Successfully Meeting Supply And Demand For Vaccine Production
View the full speaker line up at www.biologicalproduction.com/speakers/?mc=LBG6
Attendees will gain knowledge and expertise on the latest upstream and downstream strategies and single use technologies and disposables available to improve their organisational performance.
If you would like to see the programme please download the pdf from http://biop.wtginternational.com/downloadpdf_if.asp?mc=LBG6
Enjoy case studies from leading biopharmacuetical organisations including Bayer, GSK, Roche, Novartis, Pfizer, UCB, Sanofi Pasteur and discuss critical biomanufacturing issues such as QBD, cost reduction and improving upstream and downstream processes.
For more information please visit www.biologicalproduction.com?mc=LBG6, call +44 (0)207 202 7690 or email enquire@wtgevents.com.
Further details and to register
